Source: Virtual Congress 2021 – Advances in asthma treatment



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vaghi (Garbagnate Milanese (MI), Italy), L. Antonicelli (Ancona, Italy), M. Bilò (Ancona, Italy), F. De Michele (Napoli, Italy), C. Micheletto (Verona, Italy), A. Musarra (Reggio Calabria, Italy). Oral corticosteroids-related comorbidities in severe asthma. 3528

Member's Comments

No comment yet.

Related content which might interest you: Comorbidities in severe asthma Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Oral corticosteroids in the treatment of exacerbation of severe asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 Oral montelukast in patients with acute severe asthma Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Difficult-to-treat and severe asthma Source: Breathe 2014; 10: 91-94 Year: 2014 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Oral corticosteroid use in Swedish and Finnish severe asthma patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Severe asthma Source: ERS Lung Science Conference 2016 Year: 2016 Severe asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=128 Year: 2006 Severe asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019